Targeting immunoglobulin E in non-atopic asthma: crossing the red line?

Mina Gaga¹, Eleftherios Zervas², Marc Humbert^{3

4

5}

Affiliations

¹ 7th Respiratory Medicine Dept and Asthma Center, Athens Chest Hospital "Sotiria", Athens, Greece minagaga@yahoo.com.
² 7th Respiratory Medicine Dept and Asthma Center, Athens Chest Hospital "Sotiria", Athens, Greece.
³ Univ. Paris-Sud, Université Paris-Saclay, Le Kremlin Bicêtre, France.
⁴ Service de Pneumologie, Hôpital Bicêtre, Assistance Publique Hôpitaux de Paris, Le Kremlin Bicêtre, France.
⁵ INSERM UMR_S 999, Hôpital Marie Lannelongue, Le Plessis Robinson, France.

Free article

Editorial

Mina Gaga et al. Eur Respir J. 2016 Dec.

Free article

. 2016 Dec;48(6):1538-1540.

doi: 10.1183/13993003.01797-2016.

Mina Gaga¹, Eleftherios Zervas², Marc Humbert^{3

4

5}

¹ 7th Respiratory Medicine Dept and Asthma Center, Athens Chest Hospital "Sotiria", Athens, Greece minagaga@yahoo.com.
² 7th Respiratory Medicine Dept and Asthma Center, Athens Chest Hospital "Sotiria", Athens, Greece.
³ Univ. Paris-Sud, Université Paris-Saclay, Le Kremlin Bicêtre, France.
⁴ Service de Pneumologie, Hôpital Bicêtre, Assistance Publique Hôpitaux de Paris, Le Kremlin Bicêtre, France.
⁵ INSERM UMR_S 999, Hôpital Marie Lannelongue, Le Plessis Robinson, France.

No abstract available

Comment on

Omalizumab reduces bronchial mucosal IgE and improves lung function in non-atopic asthma.
Pillai P, Chan YC, Wu SY, Ohm-Laursen L, Thomas C, Durham SR, Menzies-Gow A, Rajakulasingam RK, Ying S, Gould HJ, Corrigan CJ. Pillai P, et al. Eur Respir J. 2016 Dec;48(6):1593-1601. doi: 10.1183/13993003.01501-2015. Epub 2016 Oct 20. Eur Respir J. 2016. PMID: 27824606 Clinical Trial.